TUBERCULOSIS
Clinical trials for TUBERCULOSIS explained in plain language.
Never miss a new study
Get alerted when new TUBERCULOSIS trials appear
Sign up with your email to follow new studies for TUBERCULOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Scientists test TB vaccine safety with controlled exposure
⭐️ VACCINE ⭐️ TerminatedThis early-stage study aimed to test the safety of the BCG tuberculosis vaccine in healthy adults. Researchers planned to give some participants the vaccine and then expose all participants to a weakened TB strain six months later to measure immune responses. The study was withdr…
Matched conditions: TUBERCULOSIS
Phase: PHASE1 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: ⭐️ VACCINE ⭐️
Last updated Apr 01, 2026 21:26 UTC
-
Scientists test Next-Generation shots in fight against TB
⭐️ VACCINE ⭐️ OngoingThis study is testing two new investigational vaccines designed to protect against tuberculosis (TB). Researchers are evaluating the safety and immune response of different dose levels in healthy adults who have previously received the standard BCG vaccine. The goal is to find a …
Matched conditions: TUBERCULOSIS
Phase: PHASE1, PHASE2 • Sponsor: BioNTech SE • Aim: ⭐️ VACCINE ⭐️
Last updated Mar 31, 2026 12:12 UTC
-
Oxford scientists test new TB vaccine with controlled lung challenge
⭐️ VACCINE ⭐️ OngoingThis study is testing the safety of a new tuberculosis vaccine called ID93/GLA-SE. Researchers are using a controlled infection model where 48 healthy volunteers are exposed to a weakened, harmless form of TB bacteria through inhalation. The goal is to see if the new vaccine is s…
Matched conditions: TUBERCULOSIS
Phase: NA • Sponsor: University of Oxford • Aim: ⭐️ VACCINE ⭐️
Last updated Mar 31, 2026 12:11 UTC
-
Major push for first new TB vaccine in a century
⭐️ VACCINE ⭐️ OngoingThis large, late-stage study is testing whether a new vaccine can prevent people from getting tuberculosis (TB). It will enroll over 20,000 healthy adolescents and adults, including people living with HIV, to see if the vaccine is safe and effective. Participants will receive two…
Matched conditions: TUBERCULOSIS
Phase: PHASE3 • Sponsor: Gates Medical Research Institute • Aim: ⭐️ VACCINE ⭐️
Last updated Mar 24, 2026 12:02 UTC
-
Digital & community support aim to beat TB in ethiopia
Disease control OngoingThis study is testing a new support program to help people with tuberculosis (TB) in Ethiopia stick to their medication and improve how many cases are found. The program combines family support, daily text message reminders, and special training for health workers. Researchers wi…
Matched conditions: TUBERCULOSIS
Phase: NA • Sponsor: Arba Minch University • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
AI vs. doctors: can computers find hidden TB and COVID cases?
Diagnosis OngoingThis study is testing whether a computer program that reads chest X-rays can help find cases of tuberculosis (TB) and COVID-19 more efficiently in communities in Africa. It will involve over 26,000 adults to see if using this artificial intelligence (AI) tool can speed up diagnos…
Matched conditions: TUBERCULOSIS
Phase: NA • Sponsor: University of Cape Town • Aim: Diagnosis
Last updated Mar 30, 2026 14:35 UTC
-
Race to stop TB: can a One-Month pill course beat the standard?
Prevention OngoingThis study tests two different drug regimens to prevent tuberculosis (TB) in people at high risk. It compares a shorter, daily 1-month treatment to the standard weekly 3-month treatment. The goal is to see if the shorter course is easier for people to complete and just as safe an…
Matched conditions: TUBERCULOSIS
Phase: PHASE4 • Sponsor: The Aurum Institute NPC • Aim: Prevention
Last updated Apr 01, 2026 14:41 UTC
-
Weekly pill could shield vulnerable kids from TB
Prevention OngoingThis study is checking if a weekly tuberculosis (TB) prevention treatment is safe and works well for children and teens who are living with HIV. Researchers want to see how this weekly treatment interacts with the modern HIV medications the participants are taking. The goal is to…
Matched conditions: TUBERCULOSIS
Phase: PHASE1, PHASE2 • Sponsor: The Aurum Institute NPC • Aim: Prevention
Last updated Mar 31, 2026 12:11 UTC
-
Scientists race to find best hidden TB test for vulnerable HIV patients
Knowledge-focused OngoingThis study aims to find the most effective way to screen for hidden (latent) tuberculosis in people living with HIV in Liberia. Researchers are comparing two different skin tests to see which one works better in this setting. The study involves 200 adult participants who are alre…
Matched conditions: TUBERCULOSIS
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:28 UTC
-
Scientists test inhaled TB vaccine to boost protection for High-Risk diabetics
Knowledge-focused ENROLLING_BY_INVITATIONThis study aims to see if giving a TB vaccine booster through an inhaled mist is more effective than the standard skin injection. Researchers will compare immune responses in 36 adults who received the BCG vaccine as children, including a group with type 2 diabetes. The goal is t…
Matched conditions: TUBERCULOSIS
Phase: NA • Sponsor: University of Oxford • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:28 UTC